National trends in metabolic risk of psychiatric inpatients in the United States during the atypical antipsychotic era

Gao, Y. N., & Olfson, M. (2022). National trends in metabolic risk of psychiatric inpatients in the United States during the atypical antipsychotic era. Schizophrenia Research, 248, 320–328. https://doi.org/10.1016/j.schres.2022.09.023
Authors:
Y. Nina Gao
Mark Olfson
Affiliated Authors:
Y. Nina Gao
Mark Olfson
Columbia Affiliation:
Subjects:
Antipsychotic Agents (MeSH)
Metabolic Syndrome (MeSH)
Diabetes Mellitus, Type 2 (MeSH)
Schizophrenia (MeSH)
Author Keywords:
schizophrenia
side effects-medication
metabolic syndrome
type 2 diabetes
elink
Publication Type:
Article
Unique ID:
10.1016/j.schres.2022.09.023
PMID:
36155305
DOI:
10.1016/j.schres.2022.09.023
Journal:
Schizophrenia Research
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View Web of Science Record

Record Created: